Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical-stage biopharmaceutical company developing a portfolio of potent new antibiotics designed to be effective against dangerous, drug-resistant bacteria (including multidrug-resistant (MDR) Gram-negative pathogens), today announced that Guy Macdonald, Tetraphase President and Chief Executive Officer, will present at the 16th Annual BIO CEO & Investor Conference on Tuesday, February 11th at 3:00 p.m. Eastern Time. The conference will take place February 10 – 11 at the Waldorf Astoria in New York City.
Help employers find you! Check out all the jobs and post your resume.
